Pharma Journalist - Page 860 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Santhera Selects Veeva CRM & OpenData as Commercial Software and Data Platform

LifeArc, Dstl and CDRD collaborate to identify antibacterial drug targets

NeuroVive and Yungjin Pharm Start Clinical Development in Genetic Mitochondrial Disease

QS Pharma Receives Approval from EMA for Commercial Manufacture

Allergan Introduces REFRESH OPTIVE MEGA-3 Enhanced with Flaxseed Oil

Breckenridge Pharmaceutical announces Final ANDA Approval for Azacitidine for Injection

Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial

Enanta Announces that AbbVie Receives CHMP Positive Opinion for MAVIRET

AVEO Oncology Announces Positive CHMP Opinion for Tivozanib as a Treatment of Advanced Renal Cell Carcinoma

DURECT Completes Enrollment in PERSIST, Phase 3 trial for POSIMIR